| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 434,010 | 498,810 | 455,154 | 493,062 | | Cost of Revenue | 297,652 | 354,129 | 326,838 | 370,588 | | | Gross Profit | 136,358 | 144,681 | 128,316 | 122,474 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 73,625 | 75,265 | 69,997 | 69,615 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 62,733 | 69,416 | 58,319 | 52,859 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,476 | 1,892 | (1,466) | (4,451) | | Earnings Before Interest And Taxes | 65,209 | 71,308 | 56,853 | 48,408 | | Interest Expense | 3,587 | 3,976 | 4,284 | 4,821 | | Income Before Tax | 61,622 | 67,332 | 52,569 | 43,587 | | Income Tax Expense | 20,338 | 22,051 | 17,255 | 15,023 | | Minority Interest | (1,890) |
-
|
-
| (659) | | | | Net Income From Continuing Ops | 39,478 | 45,210 | 35,880 | 28,450 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 39,478 | 45,210 | 35,880 | 28,450 | | Preferred Stock And Other Adjustments | 996 | (980) | (16) |
-
| | | Net Income Applicable To Common Shares | $40,474 | $44,230 | $35,864 | $28,450 |
|
0.29% Nasdaq 
Income Statement
